Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 22

Cited In for PubMed (Select 21872822)

1.

EWS/FLI utilizes NKX2-2 to repress mesenchymal features of Ewing sarcoma.

Fadul J, Bell R, Hoffman LM, Beckerle MC, Engel ME, Lessnick SL.

Genes Cancer. 2015 Mar;6(3-4):129-43.

2.

Primary paraesophageal Ewing's sarcoma: an uncommon case report and literature review.

Tarazona N, Navarro L, Cejalvo JM, Gambardella V, PĂ©rez-Fidalgo JA, Sempere A, Navarro S, Cervantes A.

Onco Targets Ther. 2015 May 14;8:1053-9. doi: 10.2147/OTT.S80879. eCollection 2015.

3.

Structure-function based molecular relationships in Ewing's sarcoma.

Todorova R.

Biomed Res Int. 2015;2015:798426. doi: 10.1155/2015/798426. Epub 2015 Jan 22. Review.

4.

Clinical and biochemical function of polymorphic NR0B1 GGAA-microsatellites in Ewing sarcoma: a report from the Children's Oncology Group.

Monument MJ, Johnson KM, McIlvaine E, Abegglen L, Watkins WS, Jorde LB, Womer RB, Beeler N, Monovich L, Lawlor ER, Bridge JA, Schiffman JD, Krailo MD, Randall RL, Lessnick SL.

PLoS One. 2014 Aug 5;9(8):e104378. doi: 10.1371/journal.pone.0104378. eCollection 2014.

5.

Molecular dissection of the mechanism by which EWS/FLI expression compromises actin cytoskeletal integrity and cell adhesion in Ewing sarcoma.

Chaturvedi A, Hoffman LM, Jensen CC, Lin YC, Grossmann AH, Randall RL, Lessnick SL, Welm AL, Beckerle MC.

Mol Biol Cell. 2014 Sep 15;25(18):2695-709. doi: 10.1091/mbc.E14-01-0007. Epub 2014 Jul 23.

6.

The genomic landscape of the Ewing Sarcoma family of tumors reveals recurrent STAG2 mutation.

Brohl AS, Solomon DA, Chang W, Wang J, Song Y, Sindiri S, Patidar R, Hurd L, Chen L, Shern JF, Liao H, Wen X, Gerard J, Kim JS, Lopez Guerrero JA, Machado I, Wai DH, Picci P, Triche T, Horvai AE, Miettinen M, Wei JS, Catchpool D, Llombart-Bosch A, Waldman T, Khan J.

PLoS Genet. 2014 Jul 10;10(7):e1004475. doi: 10.1371/journal.pgen.1004475. eCollection 2014 Jul. Erratum in: PLoS Genet. 2014 Aug;10(8):e1004629.

7.

Reversible LSD1 inhibition interferes with global EWS/ETS transcriptional activity and impedes Ewing sarcoma tumor growth.

Sankar S, Theisen ER, Bearss J, Mulvihill T, Hoffman LM, Sorna V, Beckerle MC, Sharma S, Lessnick SL.

Clin Cancer Res. 2014 Sep 1;20(17):4584-97. doi: 10.1158/1078-0432.CCR-14-0072. Epub 2014 Jun 24.

PMID:
24963049
8.

New strategies in ewing sarcoma: lost in translation?

Arnaldez FI, Helman LJ.

Clin Cancer Res. 2014 Jun 15;20(12):3050-6. doi: 10.1158/1078-0432.CCR-13-0633. Epub 2014 Apr 22.

9.

Distinct transcriptional signature and immunoprofile of CIC-DUX4 fusion-positive round cell tumors compared to EWSR1-rearranged Ewing sarcomas: further evidence toward distinct pathologic entities.

Specht K, Sung YS, Zhang L, Richter GH, Fletcher CD, Antonescu CR.

Genes Chromosomes Cancer. 2014 Jul;53(7):622-33. doi: 10.1002/gcc.22172. Epub 2014 Apr 10.

10.

Microsatellites with macro-influence in ewing sarcoma.

Monument MJ, Johnson KM, Grossmann AH, Schiffman JD, Randall RL, Lessnick SL.

Genes (Basel). 2012 Jul 23;3(3):444-60. doi: 10.3390/genes3030444.

11.

An overview of the role of cancer stem cells in spine tumors with a special focus on chordoma.

Safari M, Khoshnevisan A.

World J Stem Cells. 2014 Jan 26;6(1):53-64. doi: 10.4252/wjsc.v6.i1.53. Review.

12.

A multifunctional protein, EWS, is essential for early brown fat lineage determination.

Park JH, Kang HJ, Kang SI, Lee JE, Hur J, Ge K, Mueller E, Li H, Lee BC, Lee SB.

Dev Cell. 2013 Aug 26;26(4):393-404. doi: 10.1016/j.devcel.2013.07.002.

13.

Biomarkers in Ewing Sarcoma: The Promise and Challenge of Personalized Medicine. A Report from the Children's Oncology Group.

Shukla N, Schiffman J, Reed D, Davis IJ, Womer RB, Lessnick SL, Lawlor ER; COG Ewing Sarcoma Biology Committee.

Front Oncol. 2013 Jun 6;3:141. doi: 10.3389/fonc.2013.00141. eCollection 2013.

14.

Usefulness of a monoclonal ERG/FLI1 antibody for immunohistochemical discrimination of Ewing family tumors.

Tomlins SA, Palanisamy N, Brenner JC, Stall JN, Siddiqui J, Thomas DG, Lucas DR, Chinnaiyan AM, Kunju LP.

Am J Clin Pathol. 2013 Jun;139(6):771-9. doi: 10.1309/AJCPN4L1BMRQPEIT.

15.

MicroRNAs in Ewing Sarcoma.

Dylla L, Moore C, Jedlicka P.

Front Oncol. 2013 Mar 28;3:65. doi: 10.3389/fonc.2013.00065. eCollection 2013.

16.

A Decade in Banking Ewing Sarcoma: A Report from the Children's Oncology Group.

Borinstein SC, Beeler N, Block JJ, Gorlick R, Grohar P, Jedlicka P, Krailo M, Morris C, Phillips S, Siegal GP, Lawlor ER, Lessnick SL; COG Ewing Sarcoma Biology Committee.

Front Oncol. 2013 Mar 20;3:57. doi: 10.3389/fonc.2013.00057. eCollection 2013.

17.

Salient features of mesenchymal stem cells-implications for Ewing sarcoma modeling.

Monument MJ, Bernthal NM, Randall RL.

Front Oncol. 2013 Feb 25;3:24. doi: 10.3389/fonc.2013.00024. eCollection 2013.

18.

Molecular detection and targeting of EWSR1 fusion transcripts in soft tissue tumors.

Cantile M, Marra L, Franco R, Ascierto P, Liguori G, De Chiara A, Botti G.

Med Oncol. 2013 Mar;30(1):412. doi: 10.1007/s12032-012-0412-8. Epub 2013 Jan 18. Review.

19.

Characterization of Ewing sarcoma associated cancer/testis antigens.

Mahlendorf DE, Staege MS.

Cancer Biol Ther. 2013 Mar;14(3):254-61. doi: 10.4161/cbt.23298. Epub 2013 Jan 4.

20.

The EWS/FLI Oncogene Drives Changes in Cellular Morphology, Adhesion, and Migration in Ewing Sarcoma.

Chaturvedi A, Hoffman LM, Welm AL, Lessnick SL, Beckerle MC.

Genes Cancer. 2012 Feb;3(2):102-16. doi: 10.1177/1947601912457024.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk